2m Koreans opt out of life
Nearly two million individuals in Korea have formally declined life-extending medical interventions, choosing instead to prioritize their right to die with dignity when suffering from a terminal condition, data showed Sunday.
Data from the National Agency for Management of Life-Sustaining Treatment reveals that as of the end of August, 1,941,231 people have filed an advance health care directive to abstain from life-saving medical assistance since the system's inception in February 2018.
Women make up the majority of individuals opting for this choice, accounting for 68 percent, or 1,319,812, of those registered, with men accounting for the remaining 32 percent, or 621,419.
Less than 100,000 people registered for the health care directive in 2018. However, the number surged to 530,000 in 2019, 790,000 in 2020, 1,160,000 in 2021 and 1,570,000 in 2022.
Judging from the current monthly growth rate, the number is projected to exceed two million in October.
Five and half years have passed since the so-called "Death with Dignity Act" came into effect in Korea in February 2018. The act enabled people to refuse life-prolonging medical treatment.
Any adult over the age of 19 can register for the advance medical directive detailing treatment plans in the case of terminal illness, which they can also withdraw from at any time.
The necessary documents can be submitted to the National Agency for Management of Life-Sustaining Treatment, and the information will then be registered in a government database shared by hospitals and public health institutions. Life-sustaining treatment can be halted under several conditions if an individual falls terminally ill. The requirements include confirmation by a family member, approval from the ethics committee at a medical institution, and the agreement of the patient’s primary doctor and another doctor who is an expert in the field.
Currently, four types of treatment -- cardiopulmonary resuscitation, use of artificial respiration, hemodialysis and administration of anti-cancer drugs -- are categorized as life-extension care by the government.
(责任编辑:게임)
- 송영길엔 선 그은 이준석 "이낙연 싫어할 이유 없다, 긍정적"
- US approves possible sale of SM
- UN committee adopts resolution on N. Korean human rights for 19th straight year
- Hyundai Motor chair wins top UK royal honor
- Hero soldier may get honorary degree from university
- BNK Busan Bank to pilot English
- National Changgeuk Company's endeavor to foster pansori composers continues
- ‘Concrete Utopia’ clinches best picture at Daejong Film Awards
- GC Biopharma breaks ground for Indonesia’s first blood products plant
- Seoul shares close higher as US inflation softens
- National Changgeuk Company's endeavor to foster pansori composers continues
- Helicopter parent's questions spark debate online
- Passengers file complaints over burning smell on Gimpo Goldline
- [Up close in Yeouido] Spy
- Seoul stocks end nearly flat on cautious note
- [Herald Interview] Korean team wins James Dyson Award with ‘hands
- Naver's QR payment service available in 42 countries
- US approves possible sale of SM
- Half of young people struggling financially: Seoul
- Seoul subway to hold second strike Nov. 22
- [Today’s K views+
- ‘北 정찰위성 3차 발사’ 질문에 美 국방부 “계속 모니터링” views+
- Yoon doubles down on cutting national debt in 2024 budget speech views+
- NCSoft to unveil new titles at G views+
- Korea to set workplace harassment criteria: minister views+
- 악수 청한 윤 대통령에 김용민 “이제 그만두셔야죠” views+
- CJ Olive Young opens foreigner views+
- 홍준표 "서울 메가시티, 시대 역행…尹정책과도 안맞아" views+
- On verge of closing, rural school tries to lure students with financial benefits views+
- N. Korean envoy rejects report on Hamas using N. Korean arms as 'groundless' views+